KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Long-Term Investments (2019 - 2025)

Charles River Laboratories International (CRL) has 15 years of Long-Term Investments data on record, last reported at $207.0 million in Q4 2025.

  • For Q4 2025, Long-Term Investments fell 5.21% year-over-year to $207.0 million; the TTM value through Dec 2025 reached $207.0 million, down 5.21%, while the annual FY2025 figure was $207.0 million, 5.21% down from the prior year.
  • Long-Term Investments reached $207.0 million in Q4 2025 per CRL's latest filing, up from $194.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $218.4 million in Q4 2024 and bottomed at $60.6 million in Q1 2022.
  • Average Long-Term Investments over 5 years is $151.2 million, with a median of $149.6 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: skyrocketed 505.73% in 2021, then plummeted 32.83% in 2023.
  • A 5-year view of Long-Term Investments shows it stood at $149.6 million in 2021, then rose by 22.02% to $182.6 million in 2022, then tumbled by 32.83% to $122.7 million in 2023, then surged by 78.02% to $218.4 million in 2024, then decreased by 5.21% to $207.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $207.0 million in Q4 2025, $194.6 million in Q3 2025, and $216.1 million in Q2 2025.